Clark Capital Management Group, Inc. Halozyme Therapeutics, Inc. Transaction History
Clark Capital Management Group, Inc.
- $14.3 Billion
- Q3 2024
A detailed history of Clark Capital Management Group, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 137,172 shares of HALO stock, worth $6.47 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
137,172
Previous 102,925
33.27%
Holding current value
$6.47 Million
Previous $5.39 Million
45.61%
% of portfolio
0.05%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$831 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$608 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$313 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$192 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$161 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.57B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...